Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.57 |
| ▸ | DPP4 | P27487 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1756468 | 0.98 | LTA4H (0.56) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL833843 | 0.98 | LTA4H (0.56) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL8571707 | 0.98 | LTA4H (0.56) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL1333578 | 0.98 | LTA4H (0.56) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL2769963 | 0.97 | DPP4 (0.57) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL2028518 | 0.97 | DPP4 (0.57) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL14284941 | 0.97 | DPP4 (0.57) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL4280934 | 0.97 | LTA4H (0.54) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL4862372 | 0.88 | LTA4H (0.62) | LTA4HDPP4ALDH1A1KDM4ENPC1 | |
| SCHEMBL14089649 | 0.88 | DPP4 (0.44) | LTA4HDPP4ALDH1A1KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3270431-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND METHOD FOR PRODUCING PHOTOELECTRIC CONVERSION ELEMENT | FUJIFILM Corporation (JP) | 2018-01-17 | — | — | EP | disclosed |
| US-20170372847-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT | FUJIFILM CORPORATION (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170306234-A1 | LIQUID CRYSTAL COMPOSITION, METHOD OF PRODUCING THE SAME, AND RETARDATION FILM CONSTITUTED FROM THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170283700-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-05 | — | — | US | disclosed |
| US-20170145312-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | RCC1, CCDC47, ACIN1 | LTA4H 1373/4885DPP4 4668/4885ALDH1A1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.